ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) will present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023, focusing on developing novel therapies for prostate cancer treatment. David R. Parkinson, President, and CEO, along with other key executives, will host one-on-one meetings and a live webcast accessible through the company's website.

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 21, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Piper Sandler 35^th Annual Healthcare Conference on Thursday, November 30, 2023, at 12:00 p.m. ET in New York.

David. R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com, and follow us on Twitter and LinkedIn.

Contacts 

ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-piper-sandler-35th-annual-healthcare-conference-301994259.html

SOURCE ESSA Pharma Inc

FAQ

What is ESSA Pharma Inc.'s ticker symbol?

The ticker symbol for ESSA Pharma Inc. is EPIX.

When will ESSA Pharma Inc. present at the Piper Sandler 35th Annual Healthcare Conference?

ESSA Pharma Inc. will present on November 30, 2023.

What is the focus of ESSA Pharma Inc.'s development efforts?

ESSA Pharma Inc. is focused on developing novel therapies for the treatment of prostate cancer.

Who will be hosting the one-on-one meetings at the conference?

David R. Parkinson, President, and CEO, along with other key executives, will host the one-on-one meetings.

Where can the live webcast of the event be accessed?

The live webcast can be accessed in the Investors/Events & Presentations section of ESSA Pharma Inc.'s website at www.essapharma.com.

For how long will the webcast be available on the company's website?

The webcast will be archived on the ESSA Pharma Inc. website for 90 days following the event.